← Back to all trials
Completed
NCT03719339
VIRTUUS Children's Study
Conditions: Renal Transplant Rejection, Pediatric Kidney Disease, End Stage Renal Disease, Nephropathy, BK Virus (Nephropathy), Antibody-mediated Rejection, Acute Cellular Graft Rejection
Sex: All
Ages: 2 Years – 18 Years
Enrollment: 445
Sponsor: Children's Hospital of Philadelphia
Location: University of California-San Diego, Rady Children's Hospital La Jolla California
Summary
The objective of the VIRTUUS Children's Study is to adapt identified and validated adult noninvasive diagnostic and prognostic biomarkers for the characterization of allograft status in pediatric recipients of kidney allografts.
Eligibility Criteria
Inclusion Criteria:
* Males or females between 2 to 18 years at the time of recruitment
* Receiving the first, or additional, incident kidney transplants.
* Have an existing/prevalent transplant with a scheduled kidney allograft biopsy.
* Parental/guardian permission (informed consent) and, if appropriate, child assent.
Exclusion Criteria:
• Patient's primary medical team feels the subject's participation is not safe.
Source: ClinicalTrials.gov (NCT03719339). StuddyBuddy aggregates publicly available trial information.
